Histiocytoma in Dogs: The Bump That Disappears on Its Own

By Emiel Maddens  ·  Reviewed in consultation with licensed veterinary professionals  ·  Updated June 2026  ·  10 min read

Photo by Tima Miroshnichenko on Pexels

Few experiences are more alarming for a dog owner than discovering a rapidly growing bump on their young dog's skin. The instinct to fear the worst is understandable, but in dogs under three years of age, one of the most likely diagnoses is a histiocytoma, a benign tumor that, remarkably, tends to disappear on its own. Understanding what histiocytomas are, how they behave, and when they require medical attention can help ease the anxiety that comes with finding a new growth on your pet.

Histiocytomas are benign neoplasms that arise from Langerhans cells, a type of antigen-presenting dendritic cell found in the epidermis and dermis. These cells are part of the immune system's first line of defense, processing and presenting foreign antigens to T-lymphocytes. When Langerhans cells undergo neoplastic transformation, they form a compact tumor that typically appears on the skin of young dogs. The tumor grows quickly at first, often reaching its maximum size within a few weeks, before the dog's immune system recognizes and eliminates it over the following weeks to months.

This article explains the biology behind histiocytomas, how they are diagnosed, what to expect during the regression process, and the situations where veterinary intervention is needed.

What Is a Histiocytoma?

Cell of Origin: Langerhans Cells

Langerhans cells are specialized immune cells found primarily in the epidermis, the outermost layer of the skin. Their primary function is immune surveillance, capturing foreign antigens (such as bacteria, viruses, and allergens) that penetrate the skin barrier and presenting them to T-lymphocytes in the regional lymph nodes to initiate an adaptive immune response. When these cells undergo neoplastic transformation, they retain many of their normal surface markers and functional characteristics, which is why the immune system eventually recognizes the tumor as abnormal and mounts a response against it. This self-resolving behavior makes histiocytomas unique among skin tumors and is directly related to the immunological properties of the parent cell type.

Clinical Appearance

The classic histiocytoma presents as a small (typically 0.5 to 2 centimeters in diameter), firm, dome-shaped or button-like nodule that is raised above the skin surface. The overlying skin is usually hairless and may be pink, red, or slightly pigmented. The surface can be smooth or slightly ulcerated, and some histiocytomas have a characteristic "strawberry" appearance due to superficial erosion and mild bleeding. The mass is typically well-circumscribed, freely movable over deeper tissues, and not painful on palpation, though some dogs may be mildly bothered by the lesion depending on its location. Common sites include the head (particularly the ear pinnae), face, and limbs, though histiocytomas can occur anywhere on the body.

Epidemiology and Breed Predisposition

Histiocytomas are one of the most common skin tumors in dogs, accounting for approximately 10 to 14 percent of all canine skin tumors. They predominantly affect young dogs, with the vast majority occurring in dogs under three years of age and a peak incidence between one and two years. While any breed can be affected, Boxers, Dachshunds, Cocker Spaniels, Great Danes, Shetland Sheepdogs, and Bull Terriers show increased prevalence. Flat-Coated Retrievers appear predisposed to developing multiple histiocytomas. There is no significant sex predilection, with males and females affected at similar rates. The tumor is exceedingly rare in cats, making it a characteristically canine condition.

Diagnosis: Confirming It Is a Histiocytoma

Fine Needle Aspiration Cytology

Fine needle aspiration (FNA) is the most common and practical first step in diagnosing a histiocytoma. The procedure collects cells from the mass, which are then spread on a glass slide, stained, and examined under a microscope. Histiocytoma cells have a distinctive cytological appearance: they are round cells with moderate amounts of pale blue cytoplasm, eccentrically placed round to bean-shaped nuclei, and fine chromatin. The cells can resemble other round cell tumors, including mast cell tumors and lymphoma, but the absence of mast cell granules and the uniform population of cells with characteristic morphology usually points toward histiocytoma. Clinical context is important, as a rapidly appearing, solitary, dome-shaped nodule in a young dog is highly suggestive of histiocytoma even before cytology is performed.

Histopathology and Biopsy

While FNA provides a presumptive diagnosis in most cases, definitive diagnosis requires histopathological examination of an excisional or incisional biopsy specimen. Histopathology shows a dense, sheet-like proliferation of round cells in the dermis, often with involvement of the overlying epidermis (epidermotropism). During regression, the tumor shows progressive infiltration by T-lymphocytes, which can be seen on histopathology as a mixed population of neoplastic cells and small lymphocytes. Immunohistochemistry for markers such as E-cadherin, CD1a, and CD18 can confirm the Langerhans cell origin. Biopsy is particularly recommended when the mass occurs in an atypical location, in a dog over three years of age, or when it fails to regress within the expected timeframe, as these scenarios raise the index of suspicion for alternative diagnoses.

Distinguishing Histiocytoma from Look-Alikes

Several other skin tumors can closely resemble histiocytomas, making accurate diagnosis essential. Mast cell tumors, the most common malignant skin tumor in dogs, can present as small, firm, pink nodules that mimic histiocytomas, particularly in their early stages. Plasmacytomas, another round cell tumor, can appear very similar clinically and cytologically. Transmissible venereal tumors (TVTs) share the round cell morphology and can occur in young dogs, though they are primarily found on genital mucosa. Amelanotic melanomas, which lack visible pigment, can present as pink, dome-shaped nodules that may be confused with histiocytomas. The clinical context (patient age, tumor location, growth rate) combined with cytological findings usually allows differentiation, but when doubt exists, histopathology provides the definitive answer.

When Multiple Histiocytomas Appear

While solitary histiocytomas are the norm, some dogs develop multiple histiocytomas simultaneously or sequentially. Multiple histiocytomas may occur in certain breeds, particularly Flat-Coated Retrievers and Shar-Peis, and they generally follow the same self-resolving course as solitary lesions. However, multiple cutaneous histiocytic tumors must be distinguished from cutaneous histiocytosis, a reactive (non-neoplastic) histiocytic condition, and from histiocytic sarcoma, a malignant tumor with a dramatically different prognosis. Histiocytic sarcoma can arise from Langerhans cells (so-called dendritic cell sarcoma) and, unlike histiocytomas, is aggressive and progressive. Any dog with multiple histiocytic-appearing skin masses that do not regress should undergo thorough diagnostic evaluation, including biopsy with immunohistochemistry, to ensure accurate classification.

Most histiocytomas in young dogs resolve without treatment, but monitoring and documentation help ensure appropriate care.

Photo by Tima Miroshnichenko on Pexels

The Regression Process: How Histiocytomas Resolve

The Immune Response

The spontaneous regression of histiocytomas is one of the most well-studied examples of immune-mediated tumor rejection in veterinary medicine. The process begins when the dog's adaptive immune system, specifically CD8+ cytotoxic T-lymphocytes, recognizes the neoplastic Langerhans cells as abnormal and mounts a targeted attack. The T-cells infiltrate the tumor in progressively increasing numbers, directly killing tumor cells through cell-mediated cytotoxicity. This process is visible on histopathology as a band of lymphocytes (lymphocytic bandage) surrounding and infiltrating the tumor mass. As the immune response intensifies, the tumor shrinks, often becoming flatter, softer, and sometimes slightly scaly on the surface before disappearing entirely.

Timeline of Regression

The typical timeline for histiocytoma regression follows a predictable pattern. After an initial rapid growth phase lasting one to four weeks, the tumor reaches its maximum size and enters a plateau phase. Regression usually begins within four to eight weeks of initial appearance and progresses over the following one to three months. During regression, the mass may become slightly flatter, develop a rough or scaly surface, and gradually shrink in size. The entire process, from first appearance to complete disappearance, typically takes two to three months in young, immunocompetent dogs. Some histiocytomas resolve more quickly, while others take up to four months. The regression may leave a small area of scar tissue or pigmentation change at the site, which usually resolves over additional weeks.

Why Some Histiocytomas Do Not Regress

In a minority of cases, histiocytomas fail to regress within the expected three-month timeframe. This can occur in older dogs whose immune surveillance may be less robust, in dogs receiving immunosuppressive medications (such as corticosteroids or cyclosporine for allergic conditions), or in dogs with underlying immune dysfunction. In these cases, the T-cell response is insufficient to clear the tumor, and it may persist indefinitely or even continue to grow slowly. Dogs with non-regressing histiocytomas should have the mass biopsied to confirm the diagnosis and rule out other tumor types that may have been misidentified on cytology. If histiocytoma is confirmed, surgical excision is curative for non-regressing cases.

When Treatment Is Needed

Indications for Surgical Removal

While watchful waiting is appropriate for most histiocytomas, several situations warrant surgical excision. If the mass has not shown signs of regression within three months, removal and histopathological examination are recommended to confirm the diagnosis and achieve definitive treatment. Histiocytomas in locations that cause functional problems, such as on the eyelid margin where they can irritate the cornea, on the lip margin where they interfere with eating, or on the paw where they cause lameness, may warrant earlier removal. Tumors that ulcerate significantly and cause persistent bleeding or secondary infection may also benefit from early excision rather than waiting for natural resolution. The surgery is straightforward, typically involving a simple elliptical excision under sedation or general anesthesia with rapid recovery.

Managing Ulcerated Histiocytomas

Some histiocytomas develop surface ulceration during their growth phase or early regression, which can lead to minor bleeding, crusting, and risk of secondary infection. For ulcerated histiocytomas that are being monitored conservatively, topical wound care can help keep the area clean and comfortable. Gentle cleaning with a chlorhexidine-based antiseptic solution prevents bacterial colonization of the ulcerated surface. Applying a thin layer of antibiotic ointment protects the exposed tissue and promotes moist healing. Preventing the dog from licking the lesion with an Elizabethan collar is important, as saliva contains bacteria that can infect the ulcerated surface and persistent licking delays healing and regression.

Follow-Up and Monitoring

During the regression period, monitoring the histiocytoma at home is usually sufficient, with periodic veterinary check-ins as needed. Photograph the mass weekly with a size reference for objective comparison. Most veterinarians recommend a re-check at four to six weeks after initial diagnosis to assess whether regression has begun. If the mass is stable or growing at that point, another check at eight to twelve weeks is planned. By three months, if no regression has occurred, biopsy and excision are typically recommended. Once the histiocytoma has fully resolved, no further monitoring of the specific site is needed, though general skin health vigilance should continue as part of your dog's routine care.

Histiocytoma vs Other Histiocytic Diseases in Dogs

Cutaneous Histiocytosis

Cutaneous histiocytosis is a reactive (non-neoplastic) condition characterized by multiple histiocytic nodules and plaques in the skin. Unlike histiocytomas, which are solitary tumors of Langerhans cells, cutaneous histiocytosis involves interstitial dendritic cells and presents as multiple, often recurrent, skin lesions that may wax and wane over time. The condition is most commonly seen in middle-aged to older dogs and does not resolve spontaneously in the same predictable manner as histiocytomas. Treatment typically involves immunosuppressive therapy, such as cyclosporine or leflunomide, to control the reactive proliferation. Differentiating cutaneous histiocytosis from multiple histiocytomas requires histopathological examination with immunohistochemistry.

Systemic Histiocytosis

Systemic histiocytosis is a more serious condition in which histiocytic infiltration extends beyond the skin to involve lymph nodes, the nasal cavity, the respiratory tract, and other organs. It is most commonly seen in Bernese Mountain Dogs, though other breeds can be affected. Clinical signs include multiple skin nodules combined with nasal discharge, breathing difficulties, weight loss, and lethargy. The disease follows a chronic, progressive course and requires systemic immunosuppressive treatment. The prognosis is guarded, and long-term management is often necessary. This condition is categorically different from benign histiocytomas and illustrates why accurate diagnosis of any histiocytic skin tumor is important.

Histiocytic Sarcoma

Histiocytic sarcoma is a malignant cancer arising from histiocytic cells that carries a poor prognosis. It can occur in a localized form, typically as a rapidly growing mass in the skin, subcutaneous tissue, or around a joint, or in a disseminated form involving multiple organs simultaneously. Bernese Mountain Dogs, Rottweilers, Flat-Coated Retrievers, and Golden Retrievers are the most commonly affected breeds. Unlike histiocytomas, histiocytic sarcomas do not regress and are rapidly progressive without treatment. Chemotherapy with lomustine (CCNU) or combinations including doxorubicin has shown some benefit, but overall survival times remain limited. The dramatic difference in prognosis between a benign histiocytoma and a histiocytic sarcoma underscores the importance of accurate diagnosis through biopsy and immunohistochemistry.

Histiocytoma in Dogs FAQ

Q: How long does it take for a histiocytoma to go away?

Most histiocytomas resolve on their own within two to three months. The tumor typically grows rapidly for the first one to four weeks, reaches maximum size, then gradually shrinks as the immune system eliminates the abnormal cells. Some may resolve in as little as four to six weeks, while others take up to four months. If a histiocytoma has not begun to regress within three months, veterinary re-evaluation and possible biopsy are recommended.

Q: Can older dogs get histiocytomas?

While histiocytomas are most common in dogs under three years of age, they can occur in older dogs, though less frequently. When a histiocytoma-like mass appears in a dog over three years old, veterinarians tend to recommend biopsy rather than watchful waiting, because the differential diagnosis list expands with age to include more concerning tumors such as mast cell tumors and other malignancies. Older dogs may also be less likely to mount the robust immune response needed for spontaneous regression.

Q: Should I have my dog's histiocytoma removed?

In most cases, no, particularly if your dog is young and the mass is in a location that is not causing functional problems. Watchful waiting with periodic monitoring is the standard approach for a presumptive histiocytoma in a young dog. Removal is recommended if the mass does not regress within three months, if it is in a problematic location causing irritation or functional impairment, if it is significantly ulcerated and prone to infection, or if there is any uncertainty about the diagnosis based on cytology or clinical behavior.

Q: Is a histiocytoma the same as a mast cell tumor?

No, histiocytomas and mast cell tumors are completely different conditions. Histiocytomas arise from Langerhans cells, are benign, and typically resolve without treatment. Mast cell tumors arise from mast cells, are malignant in many cases, and require surgical excision and potentially additional therapy. However, both can present as small, pink, dome-shaped skin nodules, which is why cytological or histopathological examination is important to differentiate them. This distinction has major implications for treatment and prognosis.

Q: Are histiocytomas contagious to other dogs?

No, histiocytomas are not contagious. They are neoplastic growths arising from the dog's own immune cells and cannot be transmitted to other dogs, cats, or humans through contact. This distinguishes them from viral papillomas (warts), which are caused by canine papillomavirus and can spread between dogs. If your dog has a histiocytoma, there is no need to isolate them from other pets.

Sources

Fulmer, A.K. & Mauldin, G.E. (2007). Canine histiocytic neoplasia: An overview. Canadian Veterinary Journal, 48(10), 1041-1050.

Moore, P.F. (2014). A review of histiocytic diseases of dogs and cats. Veterinary Pathology, 51(1), 167-184.

Goldschmidt, M.H. & Hendrick, M.J. (2002). Tumors of the Skin and Soft Tissues. In Tumors in Domestic Animals, 4th Edition. Iowa State Press.

Gross, T.L., Ihrke, P.J., Walder, E.J., & Affolter, V.K. (2005). Skin Diseases of the Dog and Cat, 2nd Edition. Blackwell.

Vail, D.M., Thamm, D.H., & Liptak, J.M. (2019). Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition. Elsevier.

Related Reading

• Mast Cell Tumors in Dogs, Understanding the most common malignant skin tumor and why every lump needs evaluation
• Skin Tags and Warts on Dogs, Guide to common benign growths and when to worry
• Monthly Skin Check Guide, How to systematically check your dog's skin for new growths and changes
• Melanoma in Dogs, Skin versus oral melanoma and what every owner should know

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.